About This Publication:

  • Print This Page
  • Text a Friend
  • Subscribe to an RSS Feed

Sample Content 

LOGIN
My Liebert Connect

Sign up to stay informed--receive email notifications for this journal

Human Gene Therapy

Editor-in-Chief: James M. Wilson, MD, PhD
Deputy Editor: George Dickson, BSc, PhD
Human Gene Therapy Editor: Mark A. Kay, MD, PhD
Methods Editor: Thierry VandenDriessche, PhD
Clinical Development Editor: Barry J. Byrne, MD, PhD

ISSN: 1043-0342 • Published 22 issues annually • Online ISSN: 1557-7422

Current Volume: 25

Latest Impact Factor* is 4.019

*2012 Journal Citation Reports® published by Thomson Reuters, 2013

Attention Authors!
Human Gene Therapy is please to provide a full range of robust Author Services.
Click here to learn more

Human Gene Therapy
Celebrates 25 Years!
Watch an important video message from Editor-in-Chief Dr. James M. Wilson

Andenovirus Podcast Series
Brought to you by AD-VEC
Marie Curie Industry-Academia Partnerships and Pathways

Featured Press Releases and Editorial Content

  • Malcolm K. Brenner, MD, PhD Receives Pioneer Award for Advances in Gene-Modified T Cells Targeting Cancer...Read More
  • Splice-Switching Oligonucleotide Therapeutics Is Promising New Method for Editing Gene Transcripts...Read More
  • Christof von Kalle, MD, PhD Receives Pioneer Award for Contributions to Efficient Vector Integration in Human Gene Therapy...Read More
  • Frederic Bushman, PhD Receives Pioneer Award for Advancing Therapeutic Gene Delivery Methods...Read More
  • Gene Therapy Extends Survival in an Animal Model of Spinal Muscular Atrophy...Read More
  • Novel RNAi Therapy Silences Mutated Huntington's Disease Gene and Reduces Symptoms...Read More
  • James Wilson, MD, PhD Receives Pioneer Award for Research on Gene Therapy and AAV Gene Delivery Systems...Read Now
  • Pioneer Award Recipients Marina Cavazzana and Adrian Thrasher Recognized for Advancing Gene Therapy to the Clinic for Immunodeficiency Disorders...Read Now
  • Gene Therapy for Lysosomal Storage Disease Shown to Be Safe and Well Tolerated, with Promising Results...Read Now
  • Exclusive David Gancberg Article in Human Gene Therapy on European Commission Funding 2014–2015...Read Now
  • Joseph Glorioso, PhD, Receives Pioneer Award  for Engineering Herpes Simplex Virus Gene Delivery Systems...Read Now
  • Ronald Crystal, MD, Receives Pioneer Award for Developing First In Vivo Adenoviral Gene Delivery Vector...Read Now
  • Does the Body's Immune Response to Viral Vector Delivery Systems Affect the Safety or Efficacy of Gene Therapy?...Read Now
  • Top 12 Pioneer Awards for Seminal Work in Gene and Cell Therapy Selected by Blue Ribbon Panel; Essays to be Published in Human Gene Therapy...Read Now
  • Special Tribute Issue for Sonia Skarlatos, PhD
  • Abstracts: The European Society for Gene and Cell Therapy and the Spanish Society for Gene and Cell Therapy Collaborative Congress 2013
  • Editor-in-Chief Jim Wilson videocast on cell and gene therapy
    • Videocast with Dr. Wilson and John Sterling of Genetic Engineering & Biotechnology News...
      Watch Now
    • Commentary by Dr. Wilson...Read Now
    Mark Kay Appointed Editor of Human Gene Therapy; Jim Wilson Continues as Editor-in-Chief...Read More
  • Novel Gene Therapy Enables Persistent Anti-Tumor Immune Response...Read Now
  • Is Science or Hype Driving the Gene Therapy Investment "Bubble"?...Read Now
  • The Inside Story Behind the Approval of the Gene Therapy Drug Glybera—Politics and Intrigue Led to Major Milestone
    - Read the Commentary
    - Read the Review
    - Podcast with Dr. James Wilson

Overview

Human Gene Therapy is the premier, multidisciplinary journal covering all aspects of gene therapy. The Journal publishes in-depth coverage of DNA, RNA, and cell therapies by delivering the latest breakthroughs in research and technologies. Human Gene Therapy provides a central forum for scientific and clinical information, including ethical, legal, regulatory, social, and commercial issues, which enables the advancement and progress of therapeutic procedures leading to improved patient outcomes, and ultimately, to curing diseases.

The Journal is divided into three parts. Human Gene Therapy, the flagship, is published 12 times per year. HGT Methods, a bimonthly journal, focuses on the applications of gene therapy to product testing and development. New in 2013, HGT Clinical Development, a quarterly journal, serves as a venue for publishing data relevant to the regulatory review and commercial development of cell and gene therapy products.

Complete HGT Program coverage includes:

  • Improvements in vector developments
  • Delivery systems
  • Cell therapy
  • Small nucleic acid therapeutics, including RNAi
  • Clinical trials and animal models
  • Clinical protocols
  • Pre-clinical animal and in vitro studies to assess the safety of gene and cell therapy products used to support clinical applications
  • Clinical trials including those in which the results are confirmatory or negative
  • Topical issues related to the commercial development of gene and cell therapy products

Human Gene Therapy was voted one of the most influential journals in Biology and Medicine over the last 100 years by the Biomedical & Life Sciences Division of the Special Libraries Association.

Human Gene Therapy, HGT Methods, and HGT Clinical Development are under the editorial leadership of Editor-in-Chief James M. Wilson, MD, PhD, University of Pennsylvania School of Medicine, Gene Therapy Program, Department of Pathology and Laboratory Medicine; Deputy Editor Professor George Dickson, Institute of Biomedical & Life Sciences, School of Biological Sciences, University of London; Human Gene Therapy Editor Mark A. Kay, MD, PhD, Division of Human Gene Therapy, Departments of Pediatrics and Genetics, Stanford University School of Medicine; Methods Editor Thierry VandenDriessche, PhD, Free University of Brussels (VUB); Clinical Development Editor Barry J. Byrne, MD, PhD, Powell Gene Therapy Center, University of Florida, College of Medicine, and other leading investigators. View the entire editorial board.

Audience: Geneticists, medical geneticists, biological scientists, microbiologists, molecular biologists, virologists, experimental researchers, and experimental medicine specialists, among others.

Human Gene Therapy and HGT Methods provide “Instant Online” publication 72 hours after acceptance

This subscription includes:


Read Online

Editor-in-Chief: James M. Wilson, MD, PhD
ISSN: 1043-0342 • Monthly • Online ISSN: 1557-7422
Tables of Content   •   Read a Free Issue
Editorial Board   •   Author Information   •   Subscribe

Human Gene Therapy is the definitive peer-reviewed rapid-publication journal covering all aspects of human gene therapy.  The Journal publishes scientific papers on original investigations into the transfer and expression of genes in mammals, including humans with in-depth coverage of DNA, RNA, and cell therapies. Improvements in vector development, delivery systems, and animal models, particularly in the areas of cancer, heart disease, viral disease, genetic disease, and neurological disease, are covered. 



Read Online

Editor-in-Chief: James M. Wilson, MD, PhD
ISSN: 1946-6536  • Bimonthly  •  Online ISSN: 1946-6544
Editorial Board  •   Author Information  •  Subscribe

Human Gene Therapy Methods (HGT Methods) is an expansion of the flagship Human Gene Therapy, publishing technological advances in cell and gene therapy that promote the development of gene therapy products into successful therapeutics. The Journal breaks new ground as the first to exclusively focus on the applications of gene therapy to product testing and development.



Read Online

Editor-in-Chief: James M. Wilson, MD, PhD
ISSN: 1043-0342  • Quarterly  •  Online ISSN: 1557-7422
Editorial Board  •   Author Information  •  Subscribe

Human Gene Therapy Clinical Development publishes data relevant to the regulatory review and commercial development of cell and gene therapy products. Pre-clinical papers focus on pharmacology/toxicity/bio-distribution experiments used in the review of proposed clinical trials and will contain sufficient information to allow referencing between products within the same technology platform when appropriate.


[ Back to Top ]

The Official Journal of nine international societies:

DG-GT e.V.

 

Indexed/Abstracted in:

MEDLINE; PubMed; PubMed Central; Current Contents®/Life Sciences; Science Citation Index Expanded; Science Citation Index®; Biotechnology Citation Index®; Biological Abstracts; BIOSIS Previews; Journal Citation Reports/Science Edition; Derwent Drug File; EMBASE/Excerpta Medica; EMBiology; Scopus; Chemical Abstracts; ProQuest
 

Come See Us!

Show more events...

The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.

Recommended Publications

You may be interested in the following publications:

    Tissue Engineering, Parts A, B, & C

    Tissue Engineering, Parts A, B, & C

    The preeminent, biomedical journal bringing together the principles of engineering and life sciences to advance the field with cutting-edge research and applications on all aspects of tissue growth and regeneration.

    Nucleic Acid Therapeutics

    Nucleic Acid Therapeutics

    formerly Oligonucleotides

    Focuses on cutting-edge research and applications to find and examine new approaches using nucleic acids in therapeutics including oligonucleotides, gene modification, aptamers, RNA nanoparticles, ribozymes, and more.

    Stem Cells and Development

    Stem Cells and Development

    Globally recognized as the trusted source for critical, even controversial coverage of emerging hypotheses and novel findings on stem cells of all tissue types and their potential therapeutic applications.

    Zebrafish

    Zebrafish

    Solely focused on disseminating the latest cutting-edge advances in the zebrafish as a model organism for the study of vertebrate development, with attention to other aquarium species including medaka, Fugu, and Xiphophorus.

Browse All Publications »